Subsequent studies demonstrated that punicalagin at 50 μM prevented memory impairment associated with neuroinflammation by inhibiting NF-κB activation and reducing oxidative stress in LPS-treated astrocytes and microglia. This evidence concerns the gene NFKB1 and memory impairment.